Realta Investment Advisors Has $475,000 Stake in Leidos Holdings, Inc. (NYSE:LDOS)

Realta Investment Advisors boosted its position in Leidos Holdings, Inc. (NYSE:LDOS) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,227 shares of the aerospace company’s stock after purchasing an additional 157 shares during the period. Realta Investment Advisors’ holdings in Leidos were worth $475,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Rakuten Securities Inc. boosted its position in Leidos by 1,460.0% during the 3rd quarter. Rakuten Securities Inc. now owns 156 shares of the aerospace company’s stock worth $25,000 after buying an additional 146 shares during the period. Ashton Thomas Securities LLC bought a new position in shares of Leidos during the third quarter valued at $29,000. Berbice Capital Management LLC bought a new position in shares of Leidos during the fourth quarter valued at $29,000. Northwest Investment Counselors LLC acquired a new position in shares of Leidos during the third quarter worth $30,000. Finally, Mather Group LLC. grew its stake in shares of Leidos by 143.1% in the fourth quarter. Mather Group LLC. now owns 265 shares of the aerospace company’s stock worth $38,000 after purchasing an additional 156 shares during the last quarter. 76.12% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have commented on LDOS shares. The Goldman Sachs Group downgraded Leidos from a “buy” rating to a “neutral” rating and cut their target price for the stock from $228.00 to $153.00 in a report on Thursday, December 12th. Wells Fargo & Company cut their price objective on Leidos from $205.00 to $199.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Citigroup increased their target price on shares of Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Barclays boosted their price target on shares of Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Finally, UBS Group began coverage on shares of Leidos in a research report on Monday, December 2nd. They set a “neutral” rating and a $182.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $179.47.

Leidos Stock Performance

Shares of Leidos stock opened at $140.62 on Friday. The business has a 50-day simple moving average of $150.67 and a 200 day simple moving average of $157.90. The firm has a market capitalization of $18.76 billion, a price-to-earnings ratio of 16.02, a PEG ratio of 0.93 and a beta of 0.66. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15. Leidos Holdings, Inc. has a one year low of $111.95 and a one year high of $202.90.

Insider Activity

In other Leidos news, Director Noel B. Geer acquired 2,000 shares of Leidos stock in a transaction dated Wednesday, November 20th. The stock was purchased at an average cost of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the acquisition, the director now directly owns 2,000 shares of the company’s stock, valued at $322,260. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.96% of the company’s stock.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.